Market Overview

The Street Sweeper Tweets: "$SRPT up on FDA plan. Long way to go.Canaccord says if $BMRN's drug is approved 1st, pressure to approve SRPT "may decrease." We're short."

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: StreetSweeperNews Short Sellers FDA

 

Related Articles (BMRN + SRPT)

Loading...